Preventive effects of statins on the incidence of liver cancer
DOI:
https://doi.org/10.15419/bmrat.v5i3.426Abstract
Liver cancer is considered as one of the most common cancers in the world, so that it is ranked fifth in males and sixth in females in the world causing high annual costs to patients, the health system and society (Ferlay et al., 2015). The worldwide mortality rate of this disease is rising annually. This disease also has a very high fatality, so that 88% of patients in USA (Miller et al., 2016) and 90% of patients in China (Zeng et al., 2015) die of this disease in the first 5 years of its diagnosis. Therefore, it is essential to identify factors which protect against this disease. The protective effects of Statins against the cardiovascular diseases, stroke and heart attack has been proven (Tobert, 1996). Recent studies have found that Statins can also have protective effects against the cancers (Yi, Song, Wan, Chen, & Cheng, 2017). Several meta-analysis studies have explored the relationship between Statin receiving and the risk of developing liver cancer by application of randomized clinical trials, and found that the use of Statins significantly reduces the risk of liver cancer.
References
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., . . . Jemal, A. (2016). Cancer treatment and survivorship statistics, 2016. CA: a Cancer Journal for Clinicians, 66(4), 271–289. https://doi.org/10.3322/caac.21349 PMID:27253694
Pradelli, D., Soranna, D., Scotti, L., Zambon, A., Catapano, A., Mancia, G., . . . Corrao, G. (2013). Statins and primary liver cancer: A meta-analysis of observational studies. European Journal of Cancer Prevention, 22(3), 229–234. https://doi.org/10.1097/CEJ.0b013e328358761a PMID:23010949
Shi, M., Zheng, H., Nie, B., Gong, W., & Cui, X. (2014). Statin use and risk of liver cancer: An update meta-analysis. BMJ Open, 4(9), e005399. https://doi.org/10.1136/bmjopen-2014-005399 PMID:25227628
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013). Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and meta-analysis. Gastroenterology, 144(2), 323–332. https://doi.org/10.1053/j.gastro.2012.10.005 PMID:23063971
Tobert, J. A. (1996). Carcinogenicity of lipid-lowering drugs. Journal of the American Medical Association, 275(19), 1480–1482. https://doi.org/10.1001/jama.1996.03530430023029 PMID:8622219
Yi, C., Song, Z., Wan, M., Chen, Y., & Cheng, X. (2017). Statins intake and risk of liver cancer: A dose-response meta analysis of prospective cohort studies. Medicine, 96(27), e7435. https://doi.org/10.1097/MD.0000000000007435 PMID:28682909
Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., . . . Yu, X. Q. (2015). Cancer survival in China, 2003-2005: A population-based study. International Journal of Cancer, 136(8), 1921–1930. https://doi.org/10.1002/ijc.29227 PMID:25242378
Downloads
Published
Issue
Section
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
